Aim To perform a systematic review to describe the available findings on clinical outcomes
in HIV-1 and HTLV-1/HTLV-2 co-infected individuals since 1995. Design This Systematic …

Retroviral coinfections with HIV-1 and HTLV-1 or with HIV-1 and HTLV-2 occur with variable
frequencies throughout the world with the highest prevalence in large metropolitan areas in …

Human immunodeficiency virus (HIV) and human T-lymphotropic virus type I (HTLV-I) are
two retroviruses that attack the immune cells and impair their functions. Both HIV and HTLV-I …

Surveillance of emerging viral variants is critical to ensuring that blood screening and
diagnostic tests detect all infections regardless of strain or geographic location. In this study …

This article addresses the Human T-lymphotropic virus (HTLV). This subject comprises the
Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with …

Human immunodeficiency virus type 1 (HIV-1) and human T-lymphotropic virus type I (HTLV-
I) are two retroviruses which infect the same target, CD 4+ T cells. This type of cell is …

The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are
extremely important to transfusion services. We evaluated the seroprevalence of HTLV-1/2 …

O artigo aborda a infecção pelo vírus linfotrópico de células T humanas (human T
lymphotropic virus, HTLV), tema contemplado no Protocolo Clínico e Diretrizes Terapêuticas …

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human
retrovirus discovered in 1980. It is estimated that around 10–20 million people are infected …

In the literature, a great number of HIV and HTLV-I mono-infection models has been
formulated and analyzed. However, the within-host dynamics of HIV/HTLV-I co-infection has …